Literature DB >> 17585943

MR relaxometry in Huntington's disease: correlation between imaging, genetic and clinical parameters.

Josef Vymazal1, Jirí Klempír, Robert Jech, Jana Zidovská, Michael Syka, Evzen Růzicka, Jan Roth.   

Abstract

Huntington's disease (HD) is an autosomal dominant inherited neurodegenerative disease. It has been hypothesized that changes of iron content in the brain may be involved in the pathogenesis of HD. To ascertain the hypothesis, we investigated the relationship between T2 relaxation time (T2), the number of cytosine-adenine-guanine triplet repeats (CAG) and clinical status in patients suffering from HD. 34 HD patients (mean age 50.1+/-11.8 standard deviation (SD) years) and 34 control subjects (49.6+/-13.3) were scanned using a 1.5 tesla magnetic resonance (MR) scanner and the patients underwent clinical and genetic testing. A multiple echo sequence was employed for T2 measurements. T2 from healthy volunteers matched previous studies. A T2 shortening was found in the pallidum of HD patients compared to controls (65.4+/-6.4 ms vs. 71.8+/-3.6 ms, P<0.00001). A correlation between the number of CAG and T2 was found for the left pallidum (decrease in T2, P<0.05) and an inverse correlation for the left caudate (increase in T2, P<0.05). In HD patients, alterations in iron levels may be caused by an alteration in its axonal transport. The observed T2/CAG covariations may reflect changes in levels and forms of iron: this suggests that HD patients with a higher genetic load have more ferritin-bound ("safe form") iron in the pallidum and/or more low-molecular ("toxic") iron in the caudate. An increase in "toxic" iron in the caudate may enable oxidative stress and thus underlie progression of the disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17585943     DOI: 10.1016/j.jns.2007.05.018

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  13 in total

1.  pH as a biomarker of neurodegeneration in Huntington's disease: a translational rodent-human MRS study.

Authors:  Myriam M Chaumeil; Julien Valette; Céline Baligand; Emmanuel Brouillet; Philippe Hantraye; Gilles Bloch; Véronique Gaura; Amandine Rialland; Pierre Krystkowiak; Christophe Verny; Philippe Damier; Philippe Remy; Anne-Catherine Bachoud-Levi; Pierre Carlier; Vincent Lebon
Journal:  J Cereb Blood Flow Metab       Date:  2012-02-29       Impact factor: 6.200

2.  Complex relationships between cerebral blood flow and brain atrophy in early Huntington's disease.

Authors:  J Jean Chen; David H Salat; H Diana Rosas
Journal:  Neuroimage       Date:  2011-09-16       Impact factor: 6.556

3.  T2 relaxometry measurements in low spatial frequency brain regions differ between fast spin-echo and multiple-echo spin-echo sequences.

Authors:  Venkateswaran Rajagopalan; Mark J Lowe; Erik B Beall; Guang H Yue; Erik P Pioro
Journal:  MAGMA       Date:  2013-01-26       Impact factor: 2.310

4.  Seeking Huntington disease biomarkers by multimodal, cross-sectional basal ganglia imaging.

Authors:  Cristina Sánchez-Castañeda; Andrea Cherubini; Francesca Elifani; Patrice Péran; Sara Orobello; Giovanni Capelli; Umberto Sabatini; Ferdinando Squitieri
Journal:  Hum Brain Mapp       Date:  2012-02-22       Impact factor: 5.038

5.  Voxel-Based Morphometry and Relaxometry Demonstrate Macro- and Microstructural Damages in Spinocerebellar Ataxia Type 3.

Authors:  Lívia Leite Góes Gitaí; Manoel Alves Sobreira-Neto; Paula Rejane Beserra Diniz; Alan Luiz Éckeli; Regina Maria França Fernandes; Wilson Marques; Antonio Carlos Santos
Journal:  Cerebellum       Date:  2022-08-19       Impact factor: 3.648

6.  Altered brain iron content and deposition rate in Huntington's disease as indicated by quantitative susceptibility MRI.

Authors:  Lin Chen; Jun Hua; Christopher A Ross; Shuhui Cai; Peter C M van Zijl; Xu Li
Journal:  J Neurosci Res       Date:  2018-11-29       Impact factor: 4.164

7.  MRI T2 Hypointensities in basal ganglia of premanifest Huntington's disease.

Authors:  Caroline K Jurgens; Radu Jasinschi; Ahmet Ekin; Marie-Noëlle W Witjes-Ané; Huub Middelkoop; Jeroen van der Grond; Raymund A C Roos
Journal:  PLoS Curr       Date:  2010-09-08

8.  The role of iron in gray matter degeneration in Huntington's disease: a magnetic resonance imaging study.

Authors:  Cristina Sánchez-Castañeda; Ferdinando Squitieri; Margherita Di Paola; Michael Dayan; Martina Petrollini; Umberto Sabatini
Journal:  Hum Brain Mapp       Date:  2014-08-21       Impact factor: 5.038

9.  Correlation between relaxometry and diffusion tensor imaging in the globus pallidus of Huntington's disease patients.

Authors:  Michael Syka; Jiří Keller; Jiří Klempíř; Aaron M Rulseh; Jan Roth; Robert Jech; Ivan Vorisek; Josef Vymazal
Journal:  PLoS One       Date:  2015-03-17       Impact factor: 3.240

10.  Correlations of behavioral deficits with brain pathology assessed through longitudinal MRI and histopathology in the R6/2 mouse model of HD.

Authors:  Ivan Rattray; Edward Smith; Richard Gale; Kaoru Matsumoto; Gillian P Bates; Michel Modo
Journal:  PLoS One       Date:  2013-04-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.